AstraZeneca has welcomed a new registration for its asthma therapies SYMBICORT TURBUHALER and SYMBICORT RAPIHALER (budesonide and formoterol) and will be hoping for a positive outcome at November's PBAC meeting. …
Latest Video
New Stories
-
COVID-19: Pfizer the latest to announce positive vaccine data
July 3, 2020 - - Latest News -
COVID-19: Positive news on Affinity Biosciences antibodies
July 3, 2020 - - Latest News -
Funding for new Sanofi haemophilia treatments
July 3, 2020 - - Latest News -
COVID-19: New data reveals slump in new cancer treatment
July 2, 2020 - - Latest News -
COVID-19: FDA will not compromise standards on vaccine approval
July 2, 2020 - - Latest News -
Roche unveils new organisational 'system'
July 2, 2020 - - Latest News -
Mylan shareholders approve merger with Pfizer's Upjohn
July 2, 2020 - - Latest News